SCHEMBL28051498

SCHEMBL28051498

CNc1ncnc(Nc2ccc(C(F)(F)F)cc2)n1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDH2 P48735 2/20 0.53
KCNH3 Q9ULD8 1/20 0.50
SCN9A Q15858 2/20 0.48
KCNH2 Q12809 1/20 0.48
KIF11 P52732 1/20 0.47
CDK2 P24941 2/20 0.47
SYK P43405 1/20 0.47
KDM4E B2RXH2 1/20 0.47
MEN1 O00255 1/20 0.47
LMNA P02545 1/20 0.47
KMT2A Q03164 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.44
RAB9A P51151 1/20 0.44
ABL1 P00519 1/20 0.43
BCR P11274 1/20 0.43
CCNT1 O60563 1/20 0.43
CDK1 P06493 1/20 0.43
CDK4 P11802 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28037898 0.92 KCNH2 (0.54) IDH2KCNH3SCN9AKCNH2CDK2
SCHEMBL28051330 0.84 ADORA3 (0.59) KCNH3SCN9AKCNH2CDK2SYK
SCHEMBL28051487 0.83 KCNH3 (0.47) IDH2KCNH3SCN9AKCNH2CDK2
SCHEMBL27916780 0.81 LMNA (0.66) IDH2KCNH3KIF11MEN1LMNA
SCHEMBL6033558 0.81 APP (0.48) KCNH3SCN9AKCNH2CDK2SYK
SCHEMBL13064959 0.81 KDM4E (0.69) KCNH3SCN9AKCNH2CDK2SYK
SCHEMBL28051514 0.78 KCNH3 (0.79) IDH2KCNH3KIF11MEN1LMNA
SCHEMBL28051482 0.78 IDH2 (0.54) IDH2KCNH3KIF11MEN1LMNA
SCHEMBL21496175 0.78 RAB9A (0.56) SCN9AKCNH2CDK2SYKKDM4E
SCHEMBL14800688 0.77 KCNH2 (0.45) KCNH3SCN9AKCNH2CDK2SYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105294588-A Fluorotriazine-containing derivative, and preparation method and use thereof WUHAN INST TECHNOLOGY 2016-02-03 CN disclosed